About IOMICS
IOMICS is a company based in Cambridge (United States) founded in 2013. It operates as a B2B and SaaS. IOMICS offers products and services including Cures Accelerator and AI Drug Design Tools. IOMICS operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, Predictive Oncology and BigHat, among others.
- Headquarter Cambridge, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Iomics Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IOMICS
IOMICS offers a comprehensive portfolio of products and services, including Cures Accelerator and AI Drug Design Tools.
Platform for accelerating drug discovery and research through AI automation.
Tools for identifying drug targets and optimizing chemical species via machine learning.
Funding Insights of IOMICS
Detailed funding history for IOMICS
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IOMICS
Investment portfolio details for IOMICS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IOMICS
Detailed financials for IOMICS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iomics Comparisons
Peer comparison for IOMICS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IOMICS
IOMICS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, Predictive Oncology and BigHat, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| Locked | Locked | Locked |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
Detailed competitors of IOMICS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iomics
Complete news archive for IOMICS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IOMICS
IOMICS was founded in 2013.
IOMICS is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
IOMICS is a technology company that creates AI-driven platforms for systems and synthetic biology, focusing on drug discovery, repurposing, and polypharmacology. It uses machine learning to accelerate intelligent drug design and precision medicine, integrating with research pipelines. Based in Cambridge, MA, USA, it serves life sciences organizations through services like the Cures Accelerator platform. The company emphasizes data-driven innovation and seamless integration for clients in biotechnology and healthcare.
IOMICS's top competitors include Owkin, Formation Bio and XtalPi.
IOMICS offers Cures Accelerator and AI Drug Design Tools.